Screener
ARS Pharmaceuticals, Inc. SPRY Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026. Open the filing →
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
FAQ
- What is ARS Pharmaceuticals, Inc.'s price / book?
- ARS Pharmaceuticals, Inc. (SPRY) reported price / book of 13× in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s price / book changed year-over-year?
- ARS Pharmaceuticals, Inc.'s price / book increased by 141.3% year-over-year, from 5.4× to 13×.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s price / book?
- Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s price / book has grown at a 50.8% compound annual growth rate (CAGR), from 2.9× to 10.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about ARS Pharmaceuticals, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude